A detailed history of Bridgeway Capital Management, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 313,804 shares of BVS stock, worth $1.85 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
313,804
Previous 363,804 13.74%
Holding current value
$1.85 Million
Previous $1.92 Million 14.92%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$4.33 - $5.75 $216,500 - $287,500
-50,000 Reduced 13.74%
313,804 $1.63 Million
Q2 2023

Aug 14, 2023

BUY
$0.93 - $3.64 $57,097 - $223,477
61,395 Added 20.3%
363,804 $1.05 Million
Q1 2023

May 15, 2023

BUY
$1.07 - $2.95 $161,682 - $445,759
151,105 Added 99.87%
302,409 $323,000
Q4 2022

Feb 14, 2023

BUY
$1.81 - $8.14 $273,860 - $1.23 Million
151,304 New
151,304 $394,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $363M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.